Once issued, this new U.S. patent covers the use of CardiolRx™ and CRD-38 for a broad range of cardiac disorders, including atherosclerosis and heart failure, significantly expanding intellectual ...

Västerås, Sweden, September 26, 2025 - Scandinavian Real Heart AB (publ) announces today that the company has been granted patent approval by the Japan Patent Office (JPO) concerning the automatic ...

- Patent portfolio secures innovation for the future of heart replacement - TUCSON, Ariz., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), ...

TUCSON, Ariz., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first U.S. and ...

Indian Patent Office (IPO) has revoked Novartis AG’s patent on its blockbuster heart-failure drug Entresto, sold as Vymada in India, saying the Swiss drug company’s claims lacked novelty. Vymada is ...

A federal appeals court has sided with Medtronic Plc (NYSE:MDT) in a long-running patent dispute, reversing a jury's finding that the company induced infringement of a Colibri Heart Valve LLC patent ...

1.3 million patients are hospitalized annually in the U.S. from acute heart failure and it is the #1 cause of hospitalization in patients >65 years old If istaroxime is approved in the US for acute ...

SUNNYVALE, Calif. - BioCardia, Inc. (NASDAQ:BCDA), a micro-cap biotech company with a current market capitalization of $11.29 million, has been granted US Patent No. 12,311,127 for its "Radial and ...

This product is sold to you by . This product will be sold by and is therefore only available for delivery to addresses within . Returns must be sent to and will be eligible for refund only, no ...

This product is sold to you by . This product will be sold by and is therefore only available for delivery to addresses within . Returns must be sent to and will be eligible for refund only, no ...

United States Magistrate Judge James M. Wicks (E.D.N.Y.) recommended that Defendant Apple Inc.’s (“Apple”) motion to dismiss Plaintiff Joseph Wiesel’s (“Wiesel”) action for infringement of U.S. Patent ...